Cipla gets approval for distribution and marketing of inhaler insulin in India
Mumbai, December 12 (IANS). Drug maker Cipla on Wednesday said Indian regulator Central Drugs Standard Control Organization (CDSCO) has given it approval to exclusively distribute and market inhaled insulin in the country. The insulin called Afrezza is created and manufactured by MannKind Corporation, and is used to improve glycemic control in adults with diabetes mellitus. … Read more